About Brian Park, MD, MPH
Dr. Brian Park is a fellowship-trained head and neck oncologic surgeon and otolaryngologist based at our Newton and Wellesley locations. Board-certified in otolaryngology, Dr. Park sees adult patients with general otolaryngology disorders and is the director of the multidisciplinary head and neck tumor board conference at the MGH Cancer Center at Newton-Wellesley Hospital. He also serves as an associate member of the Mass Eye and Ear Division of Head and Neck Surgical Oncology in Boston. He is a member of many national otolaryngology organizations and has published a number of peer-reviewed articles in the field.
Dr. Park’s clinical interests include head and neck surgery, salivary gland surgery and nasal and sinus surgery.
Clinical Interests:
- Benign tumors of the head and neck
- Head & Neck Surgery
- Head and neck cancer
- Nasal and sinus surgery
- Otolaryngology
- Salivary Gland Surgery
- Salivary Gland Tumors
- Thyroid tumors and cervical soft tissue tumors
Treats:
- Adult
Locations
Mass. Eye and Ear at Wellesley
65 Walnut St.
Suite 590
Wellesley, MA 02481
Phone: 617-630-1699
Mass. Eye and Ear at Newton
2000 Washington St.
Suite 668
Newton, MA 02462
Phone: 617-630-1699
Medical Education
- MPH, Boston University School of Public Health
- MD, SUNY at Syracuse (Upstate) College of Medicine
- Residency, SUNY Upstate Medical University Hospital
- Fellowship, Univ. of Pittsburgh Med. Ctr.
American Board Certifications
- Otolaryngology-Head and Neck Surgery, American Board of Otolaryngology
Accepted Insurance Plans
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Harvard Pilgrim Health Plan - other
- Tufts Health Plan
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Publications
-
Park BJ, Chiosea SI, Grandis JR. "Molecular Changes in the Multistage Pathogenesis of Head and Neck Cancer." Molecular Pathology of Early Cancer. 2nd edition. Eds. Grizzle, Srivastava, & van der Sluijs. Amsterdam: IOS Press, currently in press.
Park BJ, Kalish RJ, Vercillo AP. Disseminated Plasmacytoma of the Thyroid. Ear Nose Throat Journal 89(3):137-9, 2010 Mar.
Davidson HC, Park BJ, Johnson JT. Thyroid Cancer: Controversies in the Management of Neck Metastasis. Laryngoscope. 118(12):2161-5, 2008 Dec.
Park BJ, Tatum SA. Oculoauriculovertebral Spectrum in Two Siblings. International Journal of Pediatric Otorhinolaryngology Extra 2 (3): 161-164, 2007.
Park B, Nguyen NT, Dutt P, Merdek KD, Bashar M, Sterpetti P, Tosolini A, Testa JR, Toksoz D. Association of Lbc Rho guanine nucleotide exchange factor with alpha-catenin-related protein, alpha-catulin/CTNNAL1, supports serum response factor activation. Journal of Biological Chemistry. 277(47):45361-70, 2002 Nov 22.
Sterpetti P, Hack AA, Bashar MP, Park B, Cheng SD, Knoll JH, Urano T, Feig LA, Toksoz D. Activation of the Lbc Rho exchange factor proto-oncogene by truncation of an extended C terminus that regulates transformation and targeting. Molecular & Cellular Biology. 19(2):1334-45, 1999 Feb.